NCT06245837 Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06245551 A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma Status COMPLETED Phase PHASE3
NCT06238466 A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06231693 Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil Status TERMINATED Phase N/A
NCT06230354 Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06219941 AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 Status RECRUITING Phase PHASE2
NCT06218914 Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06205498 Acalabrutinib Real World Italian obSErvational Study -ARISE Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06203704 Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients Status COMPLETED Phase N/A
NCT06201728 The Effect of Asthma Flare-up Clinic After Exacerbation Status ENROLLING_BY_INVITATION Phase NA
NCT06194825 EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06194448 To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06194032 A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants Status COMPLETED Phase PHASE1
NCT06192004 Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD Status TERMINATED Phase N/A
NCT06188520 A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2